Crossmark

Nicotinamide mononucleotide (NMN) treatment attenuates oxidative stress and rescues angiogenic capacity in aged cerebromicrovascular endothelial cells: a potential mechanism for the prevention of vascular cognitive impairment

Crossref DOI link: https://doi.org/10.1007/s11357-019-00074-2

Published Online: 2019-05-29

Published Print: 2019-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kiss, Tamas

Balasubramanian, Priya

Valcarcel-Ares, Marta Noa

Tarantini, Stefano

Yabluchanskiy, Andriy

Csipo, Tamas

Lipecz, Agnes

Reglodi, Dora

Zhang, Xin A.

Bari, Ferenc

Farkas, Eszter

Csiszar, Anna

Ungvari, Zoltan https://orcid.org/0000-0002-6035-6039
Funding

Funding for this research was provided by:

National Institute on Aging (R01-AG047879, R01-AG038747, R01-AG055395)
License Information

Text and Data Mining valid from 2019-05-29

Version of Record valid from 2019-05-29
More Information

Article History

Received: 11 May 2019

Revised: 11 May 2019

Accepted: 16 May 2019

First Online: 29 May 2019

Compliance with ethical standards

:

: The funding sources had no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the article for publication.

Document is current

Any future updates will be listed below